KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Steris (STE) EBT (2018 - 2025)

Steris has reported EBT over the past 8 years, most recently at $257.8 million for Q4 2025.

  • Quarterly results put EBT at $257.8 million for Q4 2025, up 12.72% from a year ago — trailing twelve months through Dec 2025 was $940.1 million (up 19.1% YoY), and the annual figure for FY2025 was $796.2 million, up 13.29%.
  • EBT for Q4 2025 was $257.8 million at Steris, up from $253.1 million in the prior quarter.
  • Over the last five years, EBT for STE hit a ceiling of $257.8 million in Q4 2025 and a floor of -$29.0 million in Q2 2021.
  • Median EBT over the past 5 years was $178.8 million (2021), compared with a mean of $171.2 million.
  • Biggest five-year swings in EBT: plummeted 126.68% in 2021 and later surged 603.85% in 2022.
  • Steris' EBT stood at $182.4 million in 2021, then decreased by 5.96% to $171.5 million in 2022, then increased by 10.53% to $189.6 million in 2023, then rose by 20.62% to $228.7 million in 2024, then increased by 12.72% to $257.8 million in 2025.
  • The last three reported values for EBT were $257.8 million (Q4 2025), $253.1 million (Q3 2025), and $231.9 million (Q2 2025) per Business Quant data.